Physician profile
Kaleb Howard
NPI 1073297644
$1,661.87
in general payments reported to CMS, 2019-2025
11 companies · $1,110 in 2025
The $1,110 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $303 · 2024: $248 · 2025: $1,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,661.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $356.08 | 2025 | Simplify Cervical Artificial Disc, Acp, Modulus |
| Stryker Corporation | $309.57 | 2025 | Pangea, Ozark Cervical Plate System, Triathlon |
| Axogen | $275.89 | 2023-2025 | Avance Nerve Graft |
| Paragon 28, INC. | $173.16 | 2024-2025 | Apex 3d |
| Innovation Technologies INC | $152.44 | 2023 | Irrisept |
| Biocomposites INC | $110.88 | 2024 | |
| Orthopediatrics Corp. | $105.41 | 2025 | |
| Pinnacle, INC | $71.38 | 2025 | |
| Si-Bone, INC. | $51.37 | 2024 | |
| Shockwave Medical, INC | $36.44 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Valinor Pharma, LLC | $19.25 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaleb Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.